COVID-19 pandemic The Therapeutic Goods Administration grants provisional approval to the Moderna COVID-19 vaccine for children aged 12 to 17 years old. TGA approves Moderna COVID-19 vaccine for children between 12 and 17 © 9 News Sources: 9 News